Virginia-based Owens & Minor has entered into a definitive agreement, to sell certain assets of its direct-to-consumer, diabetes supply business to Liberty Healthcare Group, Inc. for $63 million in cash.

Owens & Minor, Inc., a FORTUNE 500 company, is the leading distributor of national name-brand medical and surgical supplies and a healthcare supply-chain management company. The assets include patient data and intellectual property.

However, Owens & Minor will retain the remaining assets and liabilities, including accounts receivable.

The transaction is expected to close in early January.

During starting hours, the shares of NYSE-listed Owens & Minor were ruling at $37.67, just over the previous close of $37.64.